Insmed Inc. buy Wells Fargo & Company
Start price
20.10.25
/
50%
€143.00
Target price
20.10.26
€146.65
Performance (%)
-32.78%
Price
09:14
?
Summary
This prediction is currently active. Massive losses of -32.78% have been the result for the BUY prediction by Wells_Fargo___Compan. This prediction currently runs until 20.10.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | -3.075% | -3.075% |
| iShares Core DAX® | -1,60 % | 1,52 % |
| iShares Nasdaq 100 | 1,43 % | 1,16 % |
| iShares Nikkei 225® | 1,11 % | 1,73 % |
| iShares S&P 500 | 0,53 % | 2,97 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Insmed Inc. diskutieren
Insmed (NASDAQ:INSM) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $171.00 price target on the stock.
Ratings data for INSM provided by MarketBeat